2ypb
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='2ypb' size='340' side='right'caption='[[2ypb]], [[Resolution|resolution]] 2.87Å' scene=''> | <StructureSection load='2ypb' size='340' side='right'caption='[[2ypb]], [[Resolution|resolution]] 2.87Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2ypb]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2ypb]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2YPB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2YPB FirstGlance]. <br> |
| - | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1hlh|1hlh]], [[2ypa|2ypa]]</td></tr> | + | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1hlh|1hlh]], [[2ypa|2ypa]]</div></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2ypb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2ypb OCA], [https://pdbe.org/2ypb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2ypb RCSB], [https://www.ebi.ac.uk/pdbsum/2ypb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2ypb ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/TAL1_HUMAN TAL1_HUMAN]] Precursor T-cell acute lymphoblastic leukemia. A chromosomal aberration involving TAL1 may be a cause of some T-cell acute lymphoblastic leukemias (T-ALL). Translocation t(1;14)(p32;q11) with T-cell receptor alpha chain (TCRA) genes. [[https://www.uniprot.org/uniprot/TFE2_HUMAN TFE2_HUMAN]] Precursor B-cell acute lymphoblastic leukemia. Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family. Translocation t(17;19)(q22;p13.3) with HLF. Inversion inv(19)(p13;q13) with TFPT. |
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/TAL1_HUMAN TAL1_HUMAN]] Implicated in the genesis of hemopoietic malignancies. It may play an important role in hemopoietic differentiation. Serves as a positive regulator of erythroid differentiation (By similarity).<ref>PMID:1396592</ref> [[https://www.uniprot.org/uniprot/TFE2_HUMAN TFE2_HUMAN]] Transcriptional regulator. Involved in the initiation of neuronal differentiation. Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation. Dimers bind DNA on E-box motifs: 5'-CANNTG-3'. Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer. Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Revision as of 13:21, 4 May 2022
Structure of the SCL:E47 complex bound to DNA
| |||||||||||
Categories: Human | Large Structures | Hoosdally, S J | Karia, D | Mancini, E J | Omari, K El | Patient, R | Platonova, O | Ponsele, E | Porcher, C | Tuladhar, K | Vyas, P | Hematopoiesis | Immune system | Leukemia
